Reflect Scientific, Inc.
Reflect Scientific, Inc. RSCF Peers
See (RSCF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RSCF | $0.05 | +2.75% | 4.59M | -5.35 | -$0.01 | N/A |
| SRTOY | $22.62 | +3.86% | 220.09B | 94.25 | $0.24 | +0.17% |
| ESLOF | $293.86 | +2.65% | 134.21B | 51.28 | $5.73 | +1.36% |
| ESLOY | $145.61 | +2.59% | 132.46B | 50.74 | $2.87 | +1.00% |
| MECNY | $88.63 | N/A | 107.68B | N/A | N/A | N/A |
| SSSGY | $42.51 | +0.95% | 81.33B | 137.13 | $0.31 | +0.41% |
| SOAGY | $51.54 | -0.04% | 81.29B | 166.26 | $0.31 | +0.15% |
| HOCPY | $124.03 | +0.18% | 42.51B | 30.85 | $4.02 | +0.41% |
| HOCPF | $119.14 | -6.32% | 40.51B | 29.56 | $4.03 | +0.91% |
| TRUMY | $18.68 | +1.85% | 27.55B | 32.77 | $0.57 | +0.32% |
Stock Comparison
RSCF vs SRTOY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SRTOY has a market cap of 220.09B. Regarding current trading prices, RSCF is priced at $0.05, while SRTOY trades at $22.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SRTOY's P/E ratio is 94.25. In terms of profitability, RSCF's ROE is +0.08%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to SRTOY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs ESLOF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ESLOF has a market cap of 134.21B. Regarding current trading prices, RSCF is priced at $0.05, while ESLOF trades at $293.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ESLOF's P/E ratio is 51.28. In terms of profitability, RSCF's ROE is +0.08%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, RSCF is more volatile compared to ESLOF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs ESLOY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ESLOY has a market cap of 132.46B. Regarding current trading prices, RSCF is priced at $0.05, while ESLOY trades at $145.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ESLOY's P/E ratio is 50.74. In terms of profitability, RSCF's ROE is +0.08%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, RSCF is more volatile compared to ESLOY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs MECNY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, MECNY has a market cap of 107.68B. Regarding current trading prices, RSCF is priced at $0.05, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas MECNY's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, RSCF is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SSSGY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SSSGY has a market cap of 81.33B. Regarding current trading prices, RSCF is priced at $0.05, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SSSGY's P/E ratio is 137.13. In terms of profitability, RSCF's ROE is +0.08%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to SSSGY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SOAGY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SOAGY has a market cap of 81.29B. Regarding current trading prices, RSCF is priced at $0.05, while SOAGY trades at $51.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SOAGY's P/E ratio is 166.26. In terms of profitability, RSCF's ROE is +0.08%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs HOCPY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, HOCPY has a market cap of 42.51B. Regarding current trading prices, RSCF is priced at $0.05, while HOCPY trades at $124.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas HOCPY's P/E ratio is 30.85. In terms of profitability, RSCF's ROE is +0.08%, compared to HOCPY's ROE of +0.15%. Regarding short-term risk, RSCF is more volatile compared to HOCPY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs HOCPF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, HOCPF has a market cap of 40.51B. Regarding current trading prices, RSCF is priced at $0.05, while HOCPF trades at $119.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas HOCPF's P/E ratio is 29.56. In terms of profitability, RSCF's ROE is +0.08%, compared to HOCPF's ROE of +0.15%. Regarding short-term risk, RSCF is less volatile compared to HOCPF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs TRUMY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TRUMY has a market cap of 27.55B. Regarding current trading prices, RSCF is priced at $0.05, while TRUMY trades at $18.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TRUMY's P/E ratio is 32.77. In terms of profitability, RSCF's ROE is +0.08%, compared to TRUMY's ROE of +0.07%. Regarding short-term risk, RSCF is more volatile compared to TRUMY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs RSMDF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, RSMDF has a market cap of 26.73B. Regarding current trading prices, RSCF is priced at $0.05, while RSMDF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas RSMDF's P/E ratio is 24.72. In terms of profitability, RSCF's ROE is +0.08%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, RSCF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs TRUMF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TRUMF has a market cap of 26.39B. Regarding current trading prices, RSCF is priced at $0.05, while TRUMF trades at $17.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TRUMF's P/E ratio is 31.39. In terms of profitability, RSCF's ROE is +0.08%, compared to TRUMF's ROE of +0.07%. Regarding short-term risk, RSCF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs CLPBY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CLPBY has a market cap of 21.59B. Regarding current trading prices, RSCF is priced at $0.05, while CLPBY trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CLPBY's P/E ratio is 31.98. In terms of profitability, RSCF's ROE is +0.08%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, RSCF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SDMHF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SDMHF has a market cap of 21.50B. Regarding current trading prices, RSCF is priced at $0.05, while SDMHF trades at $221.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SDMHF's P/E ratio is 94.04. In terms of profitability, RSCF's ROE is +0.08%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to SDMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SAUHY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SAUHY has a market cap of 21.38B. Regarding current trading prices, RSCF is priced at $0.05, while SAUHY trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SAUHY's P/E ratio is 39.44. In terms of profitability, RSCF's ROE is +0.08%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, RSCF is more volatile compared to SAUHY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SAUHF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SAUHF has a market cap of 21.18B. Regarding current trading prices, RSCF is priced at $0.05, while SAUHF trades at $132.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SAUHF's P/E ratio is 38.85. In terms of profitability, RSCF's ROE is +0.08%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, RSCF is more volatile compared to SAUHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs CLPBF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CLPBF has a market cap of 20.54B. Regarding current trading prices, RSCF is priced at $0.05, while CLPBF trades at $99.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CLPBF's P/E ratio is 32.79. In terms of profitability, RSCF's ROE is +0.08%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, RSCF is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SUVPF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SUVPF has a market cap of 15.94B. Regarding current trading prices, RSCF is priced at $0.05, while SUVPF trades at $259.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SUVPF's P/E ratio is 169.29. In terms of profitability, RSCF's ROE is +0.08%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to SUVPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SARTF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SARTF has a market cap of 15.78B. Regarding current trading prices, RSCF is priced at $0.05, while SARTF trades at $203.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SARTF's P/E ratio is 132.31. In terms of profitability, RSCF's ROE is +0.08%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs OCPNF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, OCPNF has a market cap of 14.27B. Regarding current trading prices, RSCF is priced at $0.05, while OCPNF trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas OCPNF's P/E ratio is 18.33. In terms of profitability, RSCF's ROE is +0.08%, compared to OCPNF's ROE of +0.10%. Regarding short-term risk, RSCF is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs FSPKF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, FSPKF has a market cap of 12.14B. Regarding current trading prices, RSCF is priced at $0.05, while FSPKF trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas FSPKF's P/E ratio is 159.23. In terms of profitability, RSCF's ROE is +0.08%, compared to FSPKF's ROE of +0.10%. Regarding short-term risk, RSCF is less volatile compared to FSPKF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs SSMXF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SSMXF has a market cap of 10.76B. Regarding current trading prices, RSCF is priced at $0.05, while SSMXF trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SSMXF's P/E ratio is 29.74. In terms of profitability, RSCF's ROE is +0.08%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, RSCF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs SSMXY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SSMXY has a market cap of 10.55B. Regarding current trading prices, RSCF is priced at $0.05, while SSMXY trades at $16.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SSMXY's P/E ratio is 29.17. In terms of profitability, RSCF's ROE is +0.08%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, RSCF is more volatile compared to SSMXY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs CNVVY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CNVVY has a market cap of 7.45B. Regarding current trading prices, RSCF is priced at $0.05, while CNVVY trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CNVVY's P/E ratio is 39.38. In terms of profitability, RSCF's ROE is +0.08%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, RSCF is more volatile compared to CNVVY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs CNVVF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CNVVF has a market cap of 6.12B. Regarding current trading prices, RSCF is priced at $0.05, while CNVVF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CNVVF's P/E ratio is 33.33. In terms of profitability, RSCF's ROE is +0.08%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, RSCF is more volatile compared to CNVVF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs CZMWF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CZMWF has a market cap of 6.06B. Regarding current trading prices, RSCF is priced at $0.05, while CZMWF trades at $69.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CZMWF's P/E ratio is 35.14. In terms of profitability, RSCF's ROE is +0.08%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, RSCF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs CZMWY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CZMWY has a market cap of 6.05B. Regarding current trading prices, RSCF is priced at $0.05, while CZMWY trades at $69.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CZMWY's P/E ratio is 35.11. In terms of profitability, RSCF's ROE is +0.08%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, RSCF is more volatile compared to CZMWY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs YPHDF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, YPHDF has a market cap of 5.70B. Regarding current trading prices, RSCF is priced at $0.05, while YPHDF trades at $417.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas YPHDF's P/E ratio is 64.90. In terms of profitability, RSCF's ROE is +0.08%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, RSCF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs FLMNF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, FLMNF has a market cap of 5.25B. Regarding current trading prices, RSCF is priced at $0.05, while FLMNF trades at $62.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas FLMNF's P/E ratio is 34.37. In terms of profitability, RSCF's ROE is +0.08%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, RSCF is more volatile compared to FLMNF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs FLMNY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, FLMNY has a market cap of 5.11B. Regarding current trading prices, RSCF is priced at $0.05, while FLMNY trades at $12.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas FLMNY's P/E ratio is 30.40. In terms of profitability, RSCF's ROE is +0.08%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, RSCF is more volatile compared to FLMNY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs ADDLF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ADDLF has a market cap of 4.93B. Regarding current trading prices, RSCF is priced at $0.05, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, RSCF's ROE is +0.08%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, RSCF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs AHICF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, AHICF has a market cap of 4.39B. Regarding current trading prices, RSCF is priced at $0.05, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas AHICF's P/E ratio is 35.15. In terms of profitability, RSCF's ROE is +0.08%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, RSCF is more volatile compared to AHICF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SHWGY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SHWGY has a market cap of 3.00B. Regarding current trading prices, RSCF is priced at $0.05, while SHWGY trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SHWGY's P/E ratio is 11.52. In terms of profitability, RSCF's ROE is +0.08%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, RSCF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs SHWGF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SHWGF has a market cap of 2.98B. Regarding current trading prices, RSCF is priced at $0.05, while SHWGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SHWGF's P/E ratio is 11.00. In terms of profitability, RSCF's ROE is +0.08%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, RSCF is more volatile compared to SHWGF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs ANSLY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ANSLY has a market cap of 2.91B. Regarding current trading prices, RSCF is priced at $0.05, while ANSLY trades at $80.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ANSLY's P/E ratio is 24.54. In terms of profitability, RSCF's ROE is +0.08%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, RSCF is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs ANSLF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ANSLF has a market cap of 2.62B. Regarding current trading prices, RSCF is priced at $0.05, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, RSCF's ROE is +0.08%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, RSCF is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TCHBF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TCHBF has a market cap of 2.55B. Regarding current trading prices, RSCF is priced at $0.05, while TCHBF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TCHBF's P/E ratio is 31.95. In terms of profitability, RSCF's ROE is +0.08%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, RSCF is more volatile compared to TCHBF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs GRRMF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, GRRMF has a market cap of 2.52B. Regarding current trading prices, RSCF is priced at $0.05, while GRRMF trades at $73.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas GRRMF's P/E ratio is 28.67. In terms of profitability, RSCF's ROE is +0.08%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, RSCF is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TCGGY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TCGGY has a market cap of 2.31B. Regarding current trading prices, RSCF is priced at $0.05, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TCGGY's P/E ratio is 28.80. In terms of profitability, RSCF's ROE is +0.08%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, RSCF is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs EKTAY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, EKTAY has a market cap of 2.07B. Regarding current trading prices, RSCF is priced at $0.05, while EKTAY trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas EKTAY's P/E ratio is 19.07. In terms of profitability, RSCF's ROE is +0.08%, compared to EKTAY's ROE of +0.10%. Regarding short-term risk, RSCF is more volatile compared to EKTAY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs EKTAF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, EKTAF has a market cap of 1.89B. Regarding current trading prices, RSCF is priced at $0.05, while EKTAF trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas EKTAF's P/E ratio is 18.43. In terms of profitability, RSCF's ROE is +0.08%, compared to EKTAF's ROE of +0.10%. Regarding short-term risk, RSCF is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs BOEUF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, BOEUF has a market cap of 1.84B. Regarding current trading prices, RSCF is priced at $0.05, while BOEUF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas BOEUF's P/E ratio is 147.37. In terms of profitability, RSCF's ROE is +0.08%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, RSCF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TGLVY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TGLVY has a market cap of 1.50B. Regarding current trading prices, RSCF is priced at $0.05, while TGLVY trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TGLVY's P/E ratio is 75.00. In terms of profitability, RSCF's ROE is +0.08%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, RSCF is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs NPRRF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, NPRRF has a market cap of 1.50B. Regarding current trading prices, RSCF is priced at $0.05, while NPRRF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas NPRRF's P/E ratio is 44.74. In terms of profitability, RSCF's ROE is +0.08%, compared to NPRRF's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to NPRRF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs BITGF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, BITGF has a market cap of 1.15B. Regarding current trading prices, RSCF is priced at $0.05, while BITGF trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas BITGF's P/E ratio is 45.52. In terms of profitability, RSCF's ROE is +0.08%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, RSCF is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs PBHDF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, PBHDF has a market cap of 1.11B. Regarding current trading prices, RSCF is priced at $0.05, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, RSCF's ROE is +0.08%, compared to PBHDF's ROE of +0.06%. Regarding short-term risk, RSCF is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TDVXF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TDVXF has a market cap of 1.04B. Regarding current trading prices, RSCF is priced at $0.05, while TDVXF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TDVXF's P/E ratio is 66.00. In terms of profitability, RSCF's ROE is +0.08%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, RSCF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs NNCSF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, NNCSF has a market cap of 936.60M. Regarding current trading prices, RSCF is priced at $0.05, while NNCSF trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas NNCSF's P/E ratio is 102.83. In terms of profitability, RSCF's ROE is +0.08%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, RSCF is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs KSRBF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, KSRBF has a market cap of 869.34M. Regarding current trading prices, RSCF is priced at $0.05, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, RSCF's ROE is +0.08%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, RSCF is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs SPMXF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SPMXF has a market cap of 550.31M. Regarding current trading prices, RSCF is priced at $0.05, while SPMXF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SPMXF's P/E ratio is -18.00. In terms of profitability, RSCF's ROE is +0.08%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, RSCF is more volatile compared to SPMXF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs JNDOF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, JNDOF has a market cap of 531.00M. Regarding current trading prices, RSCF is priced at $0.05, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, RSCF's ROE is +0.08%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, RSCF is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs HGYMF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, HGYMF has a market cap of 524.77M. Regarding current trading prices, RSCF is priced at $0.05, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas HGYMF's P/E ratio is 33.81. In terms of profitability, RSCF's ROE is +0.08%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, RSCF is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SAFLY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SAFLY has a market cap of 449.61M. Regarding current trading prices, RSCF is priced at $0.05, while SAFLY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SAFLY's P/E ratio is 223.00. In terms of profitability, RSCF's ROE is +0.08%, compared to SAFLY's ROE of +0.00%. Regarding short-term risk, RSCF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs CLHLF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CLHLF has a market cap of 365.45M. Regarding current trading prices, RSCF is priced at $0.05, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, RSCF's ROE is +0.08%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, RSCF is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SAFLF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SAFLF has a market cap of 306.46M. Regarding current trading prices, RSCF is priced at $0.05, while SAFLF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SAFLF's P/E ratio is 12.67. In terms of profitability, RSCF's ROE is +0.08%, compared to SAFLF's ROE of +0.00%. Regarding short-term risk, RSCF is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs GUERF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, GUERF has a market cap of 281.03M. Regarding current trading prices, RSCF is priced at $0.05, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas GUERF's P/E ratio is 8.19. In terms of profitability, RSCF's ROE is +0.08%, compared to GUERF's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TSNLF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TSNLF has a market cap of 252.35M. Regarding current trading prices, RSCF is priced at $0.05, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, RSCF's ROE is +0.08%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, RSCF is more volatile compared to TSNLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs OPSSF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, OPSSF has a market cap of 247.43M. Regarding current trading prices, RSCF is priced at $0.05, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, RSCF's ROE is +0.08%, compared to OPSSF's ROE of -0.17%. Regarding short-term risk, RSCF is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs EEOIF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, EEOIF has a market cap of 63.38M. Regarding current trading prices, RSCF is priced at $0.05, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, RSCF's ROE is +0.08%, compared to EEOIF's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs UEEC Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, UEEC has a market cap of 61.69M. Regarding current trading prices, RSCF is priced at $0.05, while UEEC trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas UEEC's P/E ratio is -23.99. In terms of profitability, RSCF's ROE is +0.08%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, RSCF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs IMTH Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, IMTH has a market cap of 31.51M. Regarding current trading prices, RSCF is priced at $0.05, while IMTH trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas IMTH's P/E ratio is -1.54. In terms of profitability, RSCF's ROE is +0.08%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, RSCF is more volatile compared to IMTH. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs GVDI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, GVDI has a market cap of 16.21M. Regarding current trading prices, RSCF is priced at $0.05, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas GVDI's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, RSCF is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs OTCFF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, OTCFF has a market cap of 11.47M. Regarding current trading prices, RSCF is priced at $0.05, while OTCFF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas OTCFF's P/E ratio is -13.30. In terms of profitability, RSCF's ROE is +0.08%, compared to OTCFF's ROE of +18.74%. Regarding short-term risk, RSCF is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs YBGJ Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, YBGJ has a market cap of 9.23M. Regarding current trading prices, RSCF is priced at $0.05, while YBGJ trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas YBGJ's P/E ratio is -3.85. In terms of profitability, RSCF's ROE is +0.08%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, RSCF is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TEVNF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TEVNF has a market cap of 7.44M. Regarding current trading prices, RSCF is priced at $0.05, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TEVNF's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, RSCF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs BLMHF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, BLMHF has a market cap of 5.22M. Regarding current trading prices, RSCF is priced at $0.05, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, RSCF's ROE is +0.08%, compared to BLMHF's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs PXMVF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, PXMVF has a market cap of 4.62M. Regarding current trading prices, RSCF is priced at $0.05, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, RSCF's ROE is +0.08%, compared to PXMVF's ROE of N/A. Regarding short-term risk, RSCF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs ECIA Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ECIA has a market cap of 4.28M. Regarding current trading prices, RSCF is priced at $0.05, while ECIA trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ECIA's P/E ratio is -9.00. In terms of profitability, RSCF's ROE is +0.08%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, RSCF is more volatile compared to ECIA. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs MCDA Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, MCDA has a market cap of 4.24M. Regarding current trading prices, RSCF is priced at $0.05, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas MCDA's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to MCDA's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs CBSC Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CBSC has a market cap of 3.83M. Regarding current trading prices, RSCF is priced at $0.05, while CBSC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CBSC's P/E ratio is -3.40. In terms of profitability, RSCF's ROE is +0.08%, compared to CBSC's ROE of +1.52%. Regarding short-term risk, RSCF is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs NSTGQ Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, NSTGQ has a market cap of 3.31M. Regarding current trading prices, RSCF is priced at $0.05, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to NSTGQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs TUTH Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, TUTH has a market cap of 629427.00. Regarding current trading prices, RSCF is priced at $0.05, while TUTH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas TUTH's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to TUTH's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to TUTH. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs OJSY Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, OJSY has a market cap of 454285.00. Regarding current trading prices, RSCF is priced at $0.05, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas OJSY's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to OJSY's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs REMI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, REMI has a market cap of 399920.00. Regarding current trading prices, RSCF is priced at $0.05, while REMI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas REMI's P/E ratio is -2.00. In terms of profitability, RSCF's ROE is +0.08%, compared to REMI's ROE of -0.08%. Regarding short-term risk, RSCF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs PDMI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, PDMI has a market cap of 324879.00. Regarding current trading prices, RSCF is priced at $0.05, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas PDMI's P/E ratio is -0.01. In terms of profitability, RSCF's ROE is +0.08%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, RSCF is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SDCCQ Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SDCCQ has a market cap of 201500.00. Regarding current trading prices, RSCF is priced at $0.05, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, RSCF is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs WHSI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, WHSI has a market cap of 182671.00. Regarding current trading prices, RSCF is priced at $0.05, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas WHSI's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, RSCF is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs BLFE Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, BLFE has a market cap of 156683.00. Regarding current trading prices, RSCF is priced at $0.05, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas BLFE's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, RSCF is less volatile compared to BLFE. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs QTXB Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, QTXB has a market cap of 118045.00. Regarding current trading prices, RSCF is priced at $0.05, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas QTXB's P/E ratio is -0.05. In terms of profitability, RSCF's ROE is +0.08%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, RSCF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs CEOS Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, CEOS has a market cap of 96510.00. Regarding current trading prices, RSCF is priced at $0.05, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas CEOS's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, RSCF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs LANZ Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, LANZ has a market cap of 27690.00. Regarding current trading prices, RSCF is priced at $0.05, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas LANZ's P/E ratio is 1.00. In terms of profitability, RSCF's ROE is +0.08%, compared to LANZ's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to LANZ. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs GMVDF Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, GMVDF has a market cap of 25992.00. Regarding current trading prices, RSCF is priced at $0.05, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas GMVDF's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to GMVDF's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs INND Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, INND has a market cap of 21160.00. Regarding current trading prices, RSCF is priced at $0.05, while INND trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas INND's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to INND's ROE of +0.32%. Regarding short-term risk, RSCF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs ASFX Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ASFX has a market cap of 17502.00. Regarding current trading prices, RSCF is priced at $0.05, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ASFX's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, RSCF is more volatile compared to ASFX. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs MDIT Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, MDIT has a market cap of 8620.00. Regarding current trading prices, RSCF is priced at $0.05, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas MDIT's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, RSCF is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs DGEN Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, DGEN has a market cap of 3859.00. Regarding current trading prices, RSCF is priced at $0.05, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas DGEN's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to DGEN's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs LFPI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, LFPI has a market cap of 2042.00. Regarding current trading prices, RSCF is priced at $0.05, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas LFPI's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, RSCF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs SVSO Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SVSO has a market cap of 1276.00. Regarding current trading prices, RSCF is priced at $0.05, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SVSO's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, RSCF is less volatile compared to SVSO. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs SEYE Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SEYE has a market cap of 1159.00. Regarding current trading prices, RSCF is priced at $0.05, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SEYE's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to SEYE's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs BGMD Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, BGMD has a market cap of 1100.00. Regarding current trading prices, RSCF is priced at $0.05, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas BGMD's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, RSCF is less volatile compared to BGMD. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs ADLI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, ADLI has a market cap of 1039.00. Regarding current trading prices, RSCF is priced at $0.05, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas ADLI's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, RSCF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs VSMD Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, VSMD has a market cap of 801.00. Regarding current trading prices, RSCF is priced at $0.05, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas VSMD's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, RSCF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs HRAL Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, HRAL has a market cap of 495.00. Regarding current trading prices, RSCF is priced at $0.05, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas HRAL's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, RSCF is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for RSCF.
RSCF vs MICRD Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, MICRD has a market cap of 317.00. Regarding current trading prices, RSCF is priced at $0.05, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas MICRD's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, RSCF is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs RGBOQ Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, RGBOQ has a market cap of 97.00. Regarding current trading prices, RSCF is priced at $0.05, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, RSCF's ROE is +0.08%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs SECI Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, SECI has a market cap of 31.00. Regarding current trading prices, RSCF is priced at $0.05, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas SECI's P/E ratio is N/A. In terms of profitability, RSCF's ROE is +0.08%, compared to SECI's ROE of -0.00%. Regarding short-term risk, RSCF is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.
RSCF vs VTEQ Comparison
RSCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSCF stands at 4.59M. In comparison, VTEQ has a market cap of 1.00. Regarding current trading prices, RSCF is priced at $0.05, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSCF currently has a P/E ratio of -5.35, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, RSCF's ROE is +0.08%, compared to VTEQ's ROE of N/A. Regarding short-term risk, RSCF is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSCF.